These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20619169)
1. [Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses]. Del'Guidice T; Beaulieu JM Med Sci (Paris); 2010; 26(6-7):647-51. PubMed ID: 20619169 [TBL] [Abstract][Full Text] [Related]
2. Akt/GSK3 signaling in the action of psychotropic drugs. Beaulieu JM; Gainetdinov RR; Caron MG Annu Rev Pharmacol Toxicol; 2009; 49():327-47. PubMed ID: 18928402 [TBL] [Abstract][Full Text] [Related]
3. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. Beaulieu JM J Psychiatry Neurosci; 2012 Jan; 37(1):7-16. PubMed ID: 21711983 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drug actions on gene modulation and signaling mechanisms. Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875 [TBL] [Abstract][Full Text] [Related]
6. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia. Singh KK Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509 [TBL] [Abstract][Full Text] [Related]
7. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519 [No Abstract] [Full Text] [Related]
9. Stereochemical considerations of the actions of some psychotropic drugs. Smith DF Pharmacopsychiatry; 1985 May; 18(3):225-30. PubMed ID: 2861608 [TBL] [Abstract][Full Text] [Related]
10. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. Ozaita A; Puighermanal E; Maldonado R J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726 [TBL] [Abstract][Full Text] [Related]
11. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups. Curran S; Turner D; Musa S; Wattis J Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576 [TBL] [Abstract][Full Text] [Related]
12. National trends in psychotropic medication polypharmacy in office-based psychiatry. Mojtabai R; Olfson M Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220 [TBL] [Abstract][Full Text] [Related]
13. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. El Touny LH; Banerjee PP Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512 [TBL] [Abstract][Full Text] [Related]
15. Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients. Davis JM J Geriatr Psychiatry; 1974; 7(2):145-59. PubMed ID: 4155416 [No Abstract] [Full Text] [Related]
16. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. Cole AR FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the protein kinase B signaling pathway. Woodgett JR Curr Opin Cell Biol; 2005 Apr; 17(2):150-7. PubMed ID: 15780591 [TBL] [Abstract][Full Text] [Related]